President Donald Trump’s choice to lead the U.S. Drug Enforcement Administration, Terrance Cole, continues to be evasive about marijuana rescheduling. Trump’s nominee for DEA chief continues ...
President Donald Trump’s nominee to lead the Drug Enforcement Administration (DEA) side-stepped questions from a pair of U.S. senators related to his position on how cannabis should be scheduled ...
President Donald Trump’s nominee to head the U.S. Drug Enforcement Administration told a Senate committee that reviewing the agency’s administrative process to reclassify marijuana will be "one of ...
President Donald Trump’s nominee to head the U.S. Drug Enforcement Administration told a Senate committee that reviewing the agency’s administrative process to reclassify marijuana will be "one of ...
Despite some cannabis industry hopefuls suggesting that a President Donald Trump administration could swoop in and save the day, zero progress has been made on the rescheduling process in the past ...
A group of medical professionals who support rescheduling marijuana have dropped a lawsuit against the U.S. Drug Enforcement Administration that, among other things, accused the agency of rigging ...
A nonprofit organization of medical professionals is no longer suing the Drug Enforcement Administration (DEA) over its exclusion as a participant from the cannabis rescheduling hearing ...
The possible reclassification of marijuana under the federal Controlled Substances Act is sparking debate about dismantling barriers to interstate commerce and the future of the industry. ...
The U.S. Drug Enforcement Administration's marijuana rescheduling process "remains pending," according to a new filing. No progress at DEA on marijuana rescheduling, new filing says is a post ...
